Patent · US Active

Initial relative lymphocyte count as predictive biomarker

US9772327B2 · kind B2 · utility

2Cited by

0References

16Claims

0Family size

Assignees

Markus Heiss · DE
Michael Stroehlein · DE

Inventors

Horst Lindhofer · Puchheim, DE
Markus M. Heiss · Cologne, DE
Michael Stroehlein

Key dates

Filing date	May 16, 2012
Grant date	Sep 26, 2017
Priority date	—
Expiry date	Sep 12, 2034

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a method for predicting an improved therapeutic benefit for an individual with a tumor load before initiating an immune therapy which is capable of activating immune cells against said tumor as well as to pharmaceutical compositions for use in this method.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.